​PsiOxus Therapeutics Ltd is an award-winning UK/US development stage biotechnology company developing novel “tumour re-engineering” therapeutics for the treatment of cancer, with a focus on immunotherapeutic approaches.  We currently have two transgene-expressing T-SIGn cancer gene therapy candidates in Phase I/II clinical development and are further developing our innovative platform technology and pipeline of new pre-clinical and research candidates.  We have active collaborations in the UK & USA, including Bristol Myers Squibb, bluebirdbio (Boston) on T-SIGn combinations with CAR-T cell therapy and with the Parker Institute for Immunotherapy (San Francisco).  Our office is in Abingdon, Oxfordshire

​We are looking for an experienced Senior / Project Director to be responsible for the strategy and delivery of PsiOxus Therapeutics projects through key development milestones to market commercialisation and/or licensing according to corporate.

For all the details and how to apply please click here.